This Article Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Popovic, V. Articles by Casanueva, F. F. Search for Related Content PubMed PubMed Citation Articles by Popovic, V. Articles by Casanueva, F. F.

Ghrelin Main Action on the Regulation of Growth Hormone Release Is Exerted at Hypothalamic Level

Institute of Endocrinology, University Clinical Centre Belgrade Yugoslavia (V.P., D.Mil., D.Mic., S.D.); Division of Endocrinology (E.A., E.G.), University of Turin, Italy; Departments of Medicine (F.F.C.) and Physiology (C.D.), Complejo Hospitalario de Santiago, Santiago de Compostela University, Spain

Address correspondence to: F. F. Casanueva, M.D., Department of Medicine, Complejo Hospitalario de Santiago, Santiago de Compostela University, Santiago de Compostela, E-15780 Spain.

Abstract

Ghrelin, a recently isolated hormone, seems to participate in the physiological regulation of GH secretion. Exogenously administered ghrelin stimulates GH discharge in all species so far tested including man, but whether this action is exerted at pituitary or alternatively at hypothalamic level is not known at present. To understand the point of ghrelin action a group of patients with organic lesion mainly in the hypothalamic areq and matched controls were studied. Patients showed a severe GH deficiency after hypothalamic stimulation (ITT), but partial response after GHRH administration. Cases and controls were tested on three separate days by either ghrelin; GHRH; and ghrelin plus GHRH; always at 1 µg/Kg iv. The mean GH peak after stimulation in the patients were: 0.4 ± 0.1 µg/L by ITT; 3.1 ± 0.5 µg/L after GHRH; 2.0 ± 0.8 µg/L after ghrelin; and 9.6 ± 2.9 µg/L after the combination of GHRH plus ghrelin. In the controls GHRH induced a GH peak of 21.2 ± 7.5 µg/L, and 75.1 ± 16.0 µg/L after ghrelin with a peak after GHRH + ghrelin of 103.5 ± 26.4 µg/L. These data indicate that when hypothalamic structures are not operative ghrelin, either alone or in combination with GHRH, is not able to significantly release GH. In addition to postulating a hypothalamic point of action for the ghrelin-induced GH secretion, these results suggests that ghrelin will not have significant clinical utility in patients with GH deficiency due to organic lesion.

This article has been cited by other articles:

				F. F. Casanueva, J. P. Camina, M. C. Carreira, Y. Pazos, J. L. Varga, and A. V. Schally Growth hormone-releasing hormone as an agonist of the ghrelin receptor GHS-R1a PNAS, December 23, 2008; 105(51): 20452 - 20457. [Abstract] [Full Text] [PDF]

				R. D. Kineman and R. M. Luque Evidence that Ghrelin Is as Potent as Growth Hormone (GH)-Releasing Hormone (GHRH) in Releasing GH from Primary Pituitary Cell Cultures of a Nonhuman Primate (Papio anubis), Acting through Intracellular Signaling Pathways Distinct from GHRH Endocrinology, September 1, 2007; 148(9): 4440 - 4449. [Abstract] [Full Text] [PDF]

				M. Maghnie, M. C. Pennati, E. Civardi, N. Di Iorgi, G. Aimaretti, M. L. Foschini, G. Corneli, C. Tinelli, E. Ghigo, R. Lorini, et al. GH response to ghrelin in subjects with congenital GH deficiency: evidence that ghrelin action requires hypothalamic-pituitary connections Eur. J. Endocrinol., April 1, 2007; 156(4): 449 - 454. [Abstract] [Full Text] [PDF]

				S Pekic, M Doknic, D Miljic, M Joksimovic, J Glodic, M Djurovic, C Dieguez, F Casanueva, and V Popovic Ghrelin test for the assessment of GH status in successfully treated patients with acromegaly. Eur. J. Endocrinol., May 1, 2006; 154(5): 659 - 666. [Abstract] [Full Text] [PDF]

				N. A. Tritos and E. G. Kokkotou The Physiology and Potential Clinical Applications of Ghrelin, a Novel Peptide Hormone Mayo Clin. Proc., May 1, 2006; 81(5): 653 - 660. [Abstract] [Full Text] [PDF]

				M. Alba, D. Fintini, C. Y. Bowers, A. F. Parlow, and R. Salvatori Effects of long-term treatment with growth hormone-releasing peptide-2 in the GHRH knockout mouse Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E762 - E767. [Abstract] [Full Text] [PDF]

				M. Kojima and K. Kangawa Ghrelin: Structure and Function Physiol Rev, April 1, 2005; 85(2): 495 - 522. [Abstract] [Full Text] [PDF]

				V. Popovic, D. Miljic, S. Pekic, P. Pesko, M. Djurovic, M. Doknic, S. Damjanovic, D. Micic, G. Cvijovic, J. Glodic, et al. Low Plasma Ghrelin Level in Gastrectomized Patients Is Accompanied by Enhanced Sensitivity to the Ghrelin-Induced Growth Hormone Release J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2187 - 2191. [Abstract] [Full Text] [PDF]

				J. D. Veldhuis, J. T. Patrie, K. T. Brill, J. Y. Weltman, E. E. Mueller, C. Y. Bowers, and A. Weltman Contributions of Gender and Systemic Estradiol and Testosterone Concentrations to Maximal Secretagogue Drive of Burst-Like Growth Hormone Secretion in Healthy Middle-Aged and Older Adults J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6291 - 6296. [Abstract] [Full Text] [PDF]

				C. Maier, G. Schaller, B. Buranyi, P. Nowotny, G. Geyer, M. Wolzt, and A. Luger The Cholinergic System Controls Ghrelin Release and Ghrelin-Induced Growth Hormone Release in Humans J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4729 - 4733. [Abstract] [Full Text] [PDF]

				A. J. van der Lely, M. Tschop, M. L. Heiman, and E. Ghigo Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin Endocr. Rev., June 1, 2004; 25(3): 426 - 457. [Abstract] [Full Text] [PDF]